Update on the microbiology of cystic fibrosis: Traditional and emerging pathogens

Clinical Microbiology Newsletter

Volumn 23, Issue 9, 2001, Pages 67-71

  Whittier, Susan ^a  

^a MERIDIAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BURKHOLDERIA CEPACIA; CULTURE MEDIUM; CYSTIC FIBROSIS; HUMAN; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 0035339864     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(01)80025-8     Document Type: Article

References (27)

1. Effect of N-acetyl-cysteine on antibiotic activity and bacterial growth in vitro
2. Bacteriology of sputum in cystic fibrosis: Evaluation of dithiothreitol as a mucolytic agent
3. Microbiology of sputum from patients at cystic fibrosis centers in the United States
4. Oxacillin resistant Staphylococcus aureus in patients with cystic fibrosis
5. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis
6. Microbiology of airway disease in patients with cystic fibrosis
7. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients
8. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis
9. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection
10. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram negative nonfermenting bacilli recovered from cystic fibrosis
11. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
12. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis
13. Persistent clonal Pseudomonas cepacia infections in cystic fibrosis lung transplant recipients and clinical patients
14. Pseudomonas cepacia in lung transplant patients with cystic fibrosis
15. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of B. mulitvorans sp Nov. Int.
16. Identification and population structure of Burkholderia stabilis sp. nov. (formerly B. cepacia genomovar IV)
17. Agricultural use of Burkholderia cepacia: A threat to human health?
18. Nontuberculous mycobacteria in the adult CF patient: Colonizers or pathogens?
19. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis
20. Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of Pseudomonas aeruginosa
21. Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
22. Comparison of commercial systems for susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients
23. Efficacy of aerosolized tobramycin in patients with cystic fibrosis
24. Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic patients
25. Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods